WB, IP, ChIP
H
Endogenous
45
Rabbit IgG
#O75469
8856
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
| Immunoprecipitation | 1:50 |
| Chromatin IP | 1:50 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human
Source / Purification
Monoclonal antibody is produced by immunizing animals with recombinant human PXR protein.
Background
The pregnane X receptor (PXR) is part of the nuclear hormone receptor superfamily and is a master regulator of xenobiotic metabolism (1). PXR was initially described as being activated by pregnanes and inducing expression of the CYP3A family of steroid hydroxylases (2,3). Similar to PPAR and CAR nuclear receptors, PXR utilizes RXR as a heterodimeric partner and controls target hepatic enzyme genes to control liver metabolism in response to a wide variety of drugs (4). However, PXR is strikingly evolutionarily divergent, and the ligand-binding domain only shares around 75% identity across species. Compounds that readily activate human PXR, such as rifampicin, have little activity in rodents (5,6). In humans, in addition to naturally occurring steroids, PXR is activated by numerous xenobiotics, including anti-cancer drugs paclitaxel and tamoxifen, the HIV protease inhibitor ritonavir, and the anti-diabetic troglitazone (5,7-9). PXR has been implicated in numerous conditions, including inflammatory bowel disease, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD) (10-12). PXR plays a protective role in many tumor types and its expression is generally correlated with better prognosis (13-15).
- Kliewer, S.A. et al. (2002) Endocr Rev 23, 687-702.
- Kliewer, S.A. et al. (1998) Cell 92, 73-82.
- Lehmann, J.M. et al. (1998) J Clin Invest 102, 1016-23.
- Waxman, D.J. (1999) Arch Biochem Biophys 369, 11-23.
- Jones, S.A. et al. (2000) Mol Endocrinol 14, 27-39.
- LeCluyse, E.L. (2001) Chem Biol Interact 134, 283-9.
- Dussault, I. et al. (2001) J Biol Chem 276, 33309-12.
- Synold, T.W. et al. (2001) Nat Med 7, 584-90.
- Desai, P.B. et al. (2002) Drug Metab Dispos 30, 608-12.
- Langmann, T. et al. (2004) Gastroenterology 127, 26-40.
- Makishima, M. (2005) J Pharmacol Sci 97, 177-83.
- Lee, J.H. et al. (2008) Mol Pharm 5, 60-6.
- Ouyang, N. et al. (2010) Br J Cancer 102, 1753-61.
- Masuyama, H. et al. (2016) Int J Oncol 49, 1211-20.
- Fujimura, T. et al. (2012) Cancer Sci 103, 176-80.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v nonfat dry milk, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting IP: Immunoprecipitation ChIP: Chromatin IP
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意，否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件，除非书 CST 的合法授书代表以书面形式书独接受， 否书均被拒书，并且无效。
专品专有“专供研究使用”的专专或专似的专专声明， 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的， 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专，且专用于研专用途。将专品用于专断、专防或治专目的， 或专专售（专独或作专专成）或其他商专目的而专专专品，均需要 CST 的专独专可。客专：(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品，或使用专品制造任何商专专品，(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专，或使用专品开专任何与 CST 的专品或服专专争的专品或服专， (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专，(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品， (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专